Last updated: March 12, 2024
Sponsor: Medical University Innsbruck
Overall Status: Active - Recruiting
Phase
N/A
Condition
Peripheral Arterial Occlusive Disease
Claudication
Vascular Diseases
Treatment
Revascularization
Clinical Study ID
NCT05570019
1440/2021
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients with symptomatic peripheral arterial disease (Rutherford categories 3-6)requiring revascularization.
Exclusion
Exclusion Criteria:
- patients younger than 18 years
- patients unable to give consent without legal guardians
- iodine allergy
- hyperthyroidism
- allergy to indocyanine green
- Glomerular filtration rate <30ml/min/1.73m2
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Revascularization
Phase:
Study Start date:
October 01, 2022
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Department of Vascular Surgery, Medical University Innsbruck
Innsbruck, Tyrol 6020
AustriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.